戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ty, autoantibody production, and substantial lymphoproliferation.
2  is necessary for development of HCV-related lymphoproliferation.
3 t also causes massive double-negative T-cell lymphoproliferation.
4 m autoimmune diabetes without causing T-cell lymphoproliferation.
5 orm infection on host cytokine responses and lymphoproliferation.
6  negatively associated with rubella-specific lymphoproliferation.
7  who developed an Epstein-Barr virus-related lymphoproliferation.
8 itive patients who exhibit envelope-specific lymphoproliferation.
9 on in vitro does not preclude HIV-1-specific lymphoproliferation.
10 ormed to determine the cell type involved in lymphoproliferation.
11  cells are mainly responsible for preventing lymphoproliferation.
12 er monocytes to downregulate mitogen-induced lymphoproliferation.
13 bute to the costimulation of virally induced lymphoproliferation.
14 ion of PCD and in the inhibition of in vitro lymphoproliferation.
15 gement of the BCR in these cells, leading to lymphoproliferation.
16 ctions, hyperinflammation, autoimmunity, and lymphoproliferation.
17  combined immunodeficiency (CID), atopy, and lymphoproliferation.
18 esents as autoimmunity, inflammation, and/or lymphoproliferation.
19 ceptibility to infections, autoimmunity, and lymphoproliferation.
20 nfections, herpes viremia, autoimmunity, and lymphoproliferation.
21 matory markers, frequency of infections, and lymphoproliferation.
22 s than unlikely ALPS and had higher rates of lymphoproliferation.
23 entify high-risk patients and diagnose early lymphoproliferation.
24 ciency strongly correlated with intensity of lymphoproliferation.
25 a long-term risk of AA amyloidosis and overt lymphoproliferation.
26 lation, providing a mechanism for the T cell lymphoproliferation.
27 markers and were unable to induce allogeneic lymphoproliferation.
28 l dysfunction, perhaps related to EBV-driven lymphoproliferation.
29 isms, impaired production of antibodies, and lymphoproliferation.
30 st patients died of infection or progressive lymphoproliferation.
31 ify high-risk patients and to diagnose early lymphoproliferation.
32  confirmed the clonal B-cell nature of these lymphoproliferations.
33 tic target for treatment of some EBV-induced lymphoproliferations.
34 munodeficiency, we studied 39 EBV-associated lymphoproliferations (10 benign, 29 malignant) from four
35  the high frequency of autoimmunity (57.4%), lymphoproliferation (52.4%), noninfectious enteropathy (
36 ocyte responses at diagnosis, as measured by lymphoproliferation (7/7) or cytokine flow cytometry (3/
37 inhibition led to a reduction in spontaneous lymphoproliferation, a key ex vivo correlate of the immu
38                                  Spontaneous lymphoproliferation, a marker of T-cell activation in HA
39 ity locus Nba2 causes dramatic B cell and PC lymphoproliferation, accelerated autoantibody production
40 PS) is characterized by chronic nonmalignant lymphoproliferation, accumulation of double-negative T c
41 ng precursor to neoplastic high-grade B-cell lymphoproliferation among people with HIV, especially fo
42 ng (a) H-TdR incorporation for inhibition of lymphoproliferation and (b) flow cytometry to analyze fo
43 ify the mTOR pathway as a major regulator of lymphoproliferation and aberrant differentiation in ALPS
44 At 4 mo of age, both groups showed extensive lymphoproliferation and aberrant T cell formation, altho
45 e Fas signaling, resulting in chronic benign lymphoproliferation and accumulation of TCRalphabeta(+)
46                      WT Tregs also inhibited lymphoproliferation and acquisition of activation marker
47 had an impaired ability to induce allogeneic lymphoproliferation and activated autologous memory CD4+
48 erleukin-2 (IL-2) in T cells is critical for lymphoproliferation and an immune response.
49 es to interfere with gammaherpesvirus-driven lymphoproliferation and associated disease.
50  strategy to control gammaherpesvirus-driven lymphoproliferation and associated disease.
51 vo depletion of normal Thy-1+ cells restores lymphoproliferation and autoantibody production in such
52 induced a lupus-like chronic GVHD phenotype (lymphoproliferation and autoantibody production).
53                         Chronic nonmalignant lymphoproliferation and autoimmune cytopenia are relevan
54                                              Lymphoproliferation and autoimmune cytopenias characteri
55  linking defects in Ca(2+)/NFAT signaling to lymphoproliferation and autoimmune disease.
56 er complications resulting from infiltrative lymphoproliferation and autoimmunity are presented.
57     We found that expression of MC159 led to lymphoproliferation and autoimmunity as exemplified by T
58             Its absence leads to devastating lymphoproliferation and autoimmunity in scurfy mutant mi
59 stigated whether Bim(-/-) DCs contributed to lymphoproliferation and autoimmunity in these mice.
60 to CTLA-4-/- animals, a complete rescue from lymphoproliferation and autoimmunity was observed.
61 ocyte apoptosis are associated with abnormal lymphoproliferation and autoimmunity.
62 e a novel multisystem disease of early-onset lymphoproliferation and autoimmunity.
63 le for infectious agents in the induction of lymphoproliferation and B cell autoimmunity in MRL-lpr m
64 pport an etiological role for HCV in causing lymphoproliferation and causing non-Hodgkin lymphoma.
65       IL-2 has been implicated in regulating lymphoproliferation and CD178 (FasL) expression.
66              Cell-mediated immune responses (lymphoproliferation and cytokine production) to HPV-16 L
67 monstrated suppression of adenovirus-induced lymphoproliferation and cytokine responses (interleukin-
68 higher than increases detectable by standard lymphoproliferation and cytotoxicity assays.
69 ne adults with a history of chickenpox, by T lymphoproliferation and cytotoxicity assays.
70 y role for dietary exposure in the extent of lymphoproliferation and development of nephritis in this
71 port on 13 individuals from 10 families with lymphoproliferation and early-onset solid-organ autoimmu
72 1(-/-) and the CTLA-4/B7-2(-/-) mice develop lymphoproliferation and enhanced T cell activation.
73                          They showed massive lymphoproliferation and exacerbated inflammatory damage,
74 pr.H-2(d) mice, both types of mice developed lymphoproliferation and exhibited elevated levels of IgG
75       However, Sf.Il2-/- mice have increased lymphoproliferation and FasL expression.
76 TLA4Ig treatment of CTLA-4 -/- mice prevents lymphoproliferation and fatal multiorgan tissue damage i
77 ce of these drugs were also tested using the lymphoproliferation and flow cytometric assays.
78 ymph nodes (MLN), and spleen were assayed by lymphoproliferation and flow cytometry for the expressio
79 ogical activity of each subset, expressed as lymphoproliferation and gamma interferon (IFN-gamma) pro
80 atients without clinically detectable B-cell lymphoproliferation and generates many large B-cell clon
81      Adoptive transfer assays revealed lower lymphoproliferation and greater cell surface TGF-beta ex
82 ovide insight into mechanisms of EBV-induced lymphoproliferation and identify potential therapeutic i
83                        The gammadelta T-cell lymphoproliferation and IFN-gamma production to stimulat
84 with this haplotype demonstrated higher mean lymphoproliferation and IFN-gamma secretion than did cel
85                SP-D NCRD no longer decreased lymphoproliferation and IL-2 cytokine production when CT
86 ess safety, pharmacokinetics, and effects on lymphoproliferation and immune dysregulation.
87 eviously shown to be important in preventing lymphoproliferation and immunodeficiency following infec
88 eficiency syndrome (MAIDS), characterized by lymphoproliferation and immunodeficiency in susceptible
89                                              Lymphoproliferation and immunodeficiency, the hallmarks
90  of virus-specific T cells and occurrence of lymphoproliferation and inflammatory autoimmune disease
91 ivity correlated with mycobacterial-specific lymphoproliferation and interferon-gamma responses.
92 tvaccination H3(Beijing/32) HA (H3)-specific lymphoproliferation and interleukin (IL)-2, IL-10, and i
93 on of autoreactive T and B cells, leading to lymphoproliferation and lupus-like autoantibody producti
94  infection of BALB beta2m-/- mice results in lymphoproliferation and lymphoma, providing a valuable t
95 immune surveillance resulted in rapid, fatal lymphoproliferation and lymphomagenesis.
96 ocytes but the exact mechanism(s) leading to lymphoproliferation and MCF remained unknown.
97  exogenous sphingolipids cause inhibition of lymphoproliferation and PCD by two separate and distinct
98                           All mice exhibited lymphoproliferation and plasmacytosis.
99     Mice homozygous for the lpr gene develop lymphoproliferation and produce autoantibodies closely r
100  polyclonal lymphocyte activation leading to lymphoproliferation and severe autoimmune nephritis with
101 )CD25(+) regulatory T cells, exhibit massive lymphoproliferation and severe inflammatory infiltration
102 ty similar to that shown in vitro, including lymphoproliferation and stimulation of interleukin-6 sec
103      This paradigm is based on the extensive lymphoproliferation and systemic autoimmunity in mice an
104 ses induced by NP DNA, which included robust lymphoproliferation and Th1-type cytokine secretion (hig
105 significantly down-regulated antigen-induced lymphoproliferation and the expression of interleukin-12
106 ontrols, BEL dose-dependently inhibited both lymphoproliferation and Treg generation in human leukocy
107 activation of T cells (LAT) show progressive lymphoproliferation and ultimately die at 4-6 mo age.
108 rhal fever, a fatal disease characterized by lymphoproliferation and vasculitis.
109 nsistent TRAF1 overexpression in EBV-induced lymphoproliferations and Hodgkin's disease.
110 s influences the phenotype of the developing lymphoproliferations and potentially the severity of dis
111 n bile duct-ligated (BDL) Fas-deficient lpr (lymphoproliferation) and wild-type mice.
112 logical changes in lymphoid organs, abnormal lymphoproliferation, and a greatly increased incidence o
113 on that leads to abnormalities of apoptosis, lymphoproliferation, and a lupus-like autoimmune disease
114 s and is often associated with leukocytosis, lymphoproliferation, and autoimmune phenomena.
115 es with immunodeficiency coupled with atopy, lymphoproliferation, and cytokine overproduction harbori
116 s, antibody-dependent cellular cytotoxicity, lymphoproliferation, and cytotoxic CD8+ T cell activity
117  patients displayed multiorgan autoimmunity, lymphoproliferation, and delayed-onset mycobacterial dis
118                 One patient had nonmalignant lymphoproliferation, and four had malignant PTLD, as ass
119 g from infection, in the absence of in vitro lymphoproliferation, and from vaccination.
120 r protein) cause a syndrome of autoimmunity, lymphoproliferation, and humoral immune deficiency.
121 ty to infection with encapsulated organisms, lymphoproliferation, and hypogammaglobulinemia.
122                       Serial PPD induration, lymphoproliferation, and interferon-gamma responses.
123 stations-allergy, autoimmunity/inflammation, lymphoproliferation, and malignancies-are known to exist
124 fects of immunosuppression on EBV-associated lymphoproliferation, and may be an essential technique f
125 e dysregulation manifesting as autoimmunity, lymphoproliferation, and organ inflammation and thereby
126     Knocking out CTLA4 in mice causes lethal lymphoproliferation, and polymorphisms in human CTLA4 ar
127  STAT3 present with multiorgan autoimmunity, lymphoproliferation, and recurrent infections.
128 ns of SNPs with measles-specific antibodies, lymphoproliferation, and secreted cytokines were determi
129 mmatory arthropathy, intermittent polyclonal lymphoproliferation, and significant chronic kidney dise
130 , which corresponded to antibody production, lymphoproliferation, and skin testing.
131  in delayed-type hypersensitivity responses, lymphoproliferation, and spontaneous apoptosis and with
132 these individuals were sick, with infection, lymphoproliferation, and/or autoimmunity.
133  tissue, in Epstein-Barr virus (EBV)-induced lymphoproliferations, and in malignant lymphomas with sp
134                                              Lymphoproliferation, apoptosis functional test, and DNTs
135            Lytic gene expression in sites of lymphoproliferation appears to make a vital contribution
136 ar lymphocytic leukemias (T-LGLs) are clonal lymphoproliferations arising from either natural killer
137 indicative of lymphoaccumulation rather than lymphoproliferation as the cause of MZ expansion.
138 d the activation of autoreactive T cells and lymphoproliferation as well as production of autoantibod
139 repeat RT-PCR, nested DNA PCR, western blot, lymphoproliferation assay, cytotoxic T-cell lysis, CD8-d
140                                              Lymphoproliferation assays and cytokine enzyme-linked im
141                                              Lymphoproliferation assays measured functional responses
142 )-gamma enzyme-linked immunosorbent spot and lymphoproliferation assays.
143 chronic stimulation of the immune system and lymphoproliferation associated with storage of glucocere
144       Foxo3a deficiency leads to spontaneous lymphoproliferation, associated with inflammation of sev
145 s for one such subject revealed Env-specific lymphoproliferation at 11 DPI but no detectable Env-spec
146 family presenting with EBV-associated B-cell lymphoproliferation at an early age (12, 7(1/2), and 14
147 mmunosuppressive, inhibiting antigen-induced lymphoproliferation at micromolar concentrations.
148 lity to infections and include autoimmunity, lymphoproliferation, atopy, and inflammation.
149 iciency for the IFN-RI surprisingly worsened lymphoproliferation, autoantibody production, and end or
150 e array of immune-mediated disease including lymphoproliferation, autoimmune cytopenias, and multisys
151 apoptosis of lymphocytes is characterized by lymphoproliferation, autoimmunity, but also an increased
152 linical manifestations including infections, lymphoproliferation, autoimmunity, enteropathy, bronchie
153 nt recipients are at high risk of EBV-driven lymphoproliferation because they lack EBV-specific memor
154 s to be required for uncontrolled aggressive lymphoproliferation, because none of the IL-15Ralpha(-/-
155 t antitumor effects in EBV-associated B-cell lymphoproliferations both in vitro and in vivo.
156  which was initially attributed to excessive lymphoproliferation but is now ascribed to the absence o
157                 However, MPA alone inhibited lymphoproliferation but significantly enhanced Treg gene
158 e that overexpression of this locus leads to lymphoproliferation, but no experimental proof that dysr
159 e sensitivity of peripheral monitoring for B lymphoproliferation, but the dramatic reduction in PTLD
160 volved in the pathogenesis of several B cell lymphoproliferations, but the precise contribution it ma
161 induced tolerance and double-negative T-cell lymphoproliferation can be uncoupled from each other.
162 tic cows, demonstrating that the spontaneous lymphoproliferation characteristic of BLV-induced persis
163 gnificantly exacerbated the skin disease and lymphoproliferation characteristic of MRL/lpr mice.
164  factor pathway by EBV may contribute to the lymphoproliferation characteristic of type III latency.
165 s similarities and differences of the murine lymphoproliferations compared with human CLL.
166 biopsy revealed an Epstein-Barr virus-driven lymphoproliferation consistent with a polymorphic posttr
167 ystemic disease, in the form of unrestrained lymphoproliferation, continued unabated.
168 ayed type hypersensitivity (DTH) and in vivo lymphoproliferation correlated with MMc levels, suggesti
169  E7 and/or L1-specific WIL, as determined by lymphoproliferation, could be isolated from more than 75
170                   DKO mice exhibit increased lymphoproliferation, decreased activation-induced cell d
171            Comparing HCDR3 regions of CD5(+) lymphoproliferations derived from this and published CLL
172 deleted region (CDR) changed the spectrum of lymphoproliferations developing in CDR- versus MDR-delet
173 e resulting FADD mutant mice did not develop lymphoproliferation diseases, unlike Fas-deficient mice.
174  immune regulatory disorder characterized by lymphoproliferation, dysgammaglobulinemia, and multiorga
175 munodeficiency associated with erythroderma, lymphoproliferation, elevated IgE, and hyperactive oligo
176  the Notch1 intracellular domain resulted in lymphoproliferation, exacerbated T(H)1 responses and aut
177                                  As shown by lymphoproliferation experiments, they contained allergen
178 man immunodeficiency virus-negative atypical lymphoproliferations expressing large amounts of the lat
179  and conventional MRL-lpr mice were noted in lymphoproliferation, flow cytometric analysis of lymph n
180               Several mice harbored abnormal lymphoproliferations following therapy--in these cases,
181 noculated intradermally into wild type (wt), lymphoproliferation gene (lpr) (Fas deficient), or gener
182 apoptotic pathway, and its role in mediating lymphoproliferation has been extensively examined.
183            Most studies of EBV infection and lymphoproliferation have focused on the pediatric age gr
184 dies, 77% of patients with envelope-specific lymphoproliferation have undetectable anti-CD4bd antibod
185           The simplest way of preventing EBV lymphoproliferation, however, may be to deplete B cells
186 mber of immunopathologic sequelae, including lymphoproliferation, hypergammaglobulinemia, and overt s
187 tion with autoimmunity, immunodeficiency and lymphoproliferation (IDAIL).
188 phomas, 4 systemic lymphomas, and 4 atypical lymphoproliferations, ie, in 60% of cases.
189 o 8 weeks after infection by the criteria of lymphoproliferation, impaired proliferative responses to
190 ons, persistent EBV viremia, and EBV-induced lymphoproliferation in 2 unrelated patients.
191 motes rather than inhibits Bcr-Abl-induced B lymphoproliferation in a murine model where BM cells fro
192 e of T-cell epitopes was determined based on lymphoproliferation in allergic patients.
193 important early event in the pathogenesis of lymphoproliferation in ALPS patients.
194 rom CTLA-4(-/-) mice engrafted and prevented lymphoproliferation in an in vivo murine model of CTLA-4
195            Pristane treatment also decreased lymphoproliferation in B6/lpr mice.
196                       However, MP stimulated lymphoproliferation in CD4(+) T cells obtained from the
197       Long-standing immune dysregulation and lymphoproliferation in children may be life-threatening,
198 IgM(+) memory B cells as a general target of lymphoproliferation in HCV(+) patients, affecting appare
199 , our findings suggest that autoimmunity and lymphoproliferation in IL-2Ralpha-/- mice can result fro
200 ) effectively prevents and treats EBV-driven lymphoproliferation in immunocompromised hosts.
201 meostatic control may be responsible for CD4 lymphoproliferation in MAIDS.
202 with increased susceptibility to EBV-induced lymphoproliferation in patients associated with hypomorp
203 sensitivity responses and decreased in vitro lymphoproliferation in response to specific antigens hav
204    This approach accomplishes the control of lymphoproliferation in severe forms as well as the minim
205 4(+) T cells delays but does not prevent the lymphoproliferation in the CTLA-4(-/-) mice.
206  the marked decrease seen in mitogen-induced lymphoproliferation in the presence of infected monocyte
207                            We also show that lymphoproliferation in this model is closely tied to ele
208                Concomitant envelope-specific lymphoproliferation in vitro was undetectable among 9 in
209 skin test to tuberculin, and antigen-induced lymphoproliferation in vitro were markedly suppressed in
210          The dramatic reversal of EBV-driven lymphoproliferations in bone marrow transplant patients
211 recapitulates the spectrum of CLL-associated lymphoproliferations in humans, including CLL, CD5(+) mo
212 enes faithfully recapitulate the spectrum of lymphoproliferations in humans?
213                              Do the CLL-like lymphoproliferations in the mouse have the phenotypic, h
214    We investigated age-related EBV(+) B-cell lymphoproliferations in the Western population.
215 n at the single-cell level in EBV-associated lymphoproliferations in vivo.
216  differential diagnosis of extranodal T-cell lymphoproliferations, including those in immunosuppresse
217 by the production of anti-nucleolar IgG Abs, lymphoproliferation, increased serum levels of IgG1 and
218  by the production of antinucleolar IgG Abs, lymphoproliferation, increased serum levels of IgG1/IgE
219 constitutively active Raf transgene enhanced lymphoproliferation, indicating a role for the Ras-MAPK
220  activation in iMCD is not just a product of lymphoproliferation/inflammatory lymphadenopathy.
221 ignificantly increased Ag85b-specific T cell lymphoproliferation, interferon (IFN)-gamma secretion, I
222        Nine of 21 animals developed a B-cell lymphoproliferation involving peripheral blood (9 of 9),
223 T3 mutations may distinguish truly malignant lymphoproliferations involving T and NK cells from react
224   Epstein-Barr virus (EBV)-associated B-cell lymphoproliferation is a life-threatening complication a
225                                              Lymphoproliferation is believed to be caused by impaired
226                               EBV-associated lymphoproliferation is characterized by expression of la
227                          Histologically, the lymphoproliferation is characterized by plasmablasts tha
228                               Posttransplant lymphoproliferation is most often observed in pediatric
229 ninfected, nonpregnant mice, suggesting that lymphoproliferation is not a good indicator of the antim
230 CI promotes antibody production and inhibits lymphoproliferation is not understood.
231 cterized by progressive immunodeficiency and lymphoproliferation, known as murine AIDS (MAIDS).
232  was sufficient to trigger aggressive B-cell lymphoproliferation, leading to early postnatal lethalit
233 TLA-4 die at an age of 2-3 wk due to massive lymphoproliferation, leading to lymphocytic infiltration
234 homozygous gld mutations cause age-dependent lymphoproliferation, limiting the gld mutation to one al
235                     We measured HCV-specific lymphoproliferation (LP), intrahepatic cytotoxic T lymph
236                        Mice with spontaneous lymphoproliferation (lpr) and generalized lymphoprolifer
237                  Wild-type and Fas-deficient lymphoproliferation (lpr) mice underwent bile duct ligat
238 ween this syndrome and that in mice with the lymphoproliferation (lpr) phenotype or the generalized-l
239 infection, and increased incidence of B-cell lymphoproliferation, lymphoma, or both.
240 tween intrinsic B cell reactivity and lethal lymphoproliferation, lymphomagenesis, and autoinflammati
241 -nonbinding CTLA-4 mutant delayed the lethal lymphoproliferation observed in CTLA-4-deficient mice.
242  prevents all features characteristic of the lymphoproliferation observed in CTLA-4-deficient mice.
243 rlier occurrence of autoantibodies; a higher lymphoproliferation of B and T cells; and an earlier ons
244 ular lymphocyte (T-LGL) leukemia is a clonal lymphoproliferation of cytotoxic T cells (CTLs) associat
245 ular lymphocyte leukemia is a chronic clonal lymphoproliferation of cytotoxic T cells often associate
246 phocyte (T-LGL) leukemia is a chronic clonal lymphoproliferation of cytotoxic T cells often associate
247 eukemia (T-LGLL) is characterized by chronic lymphoproliferation of cytotoxic T lymphocytes (CTLs) an
248 a (T-LGL) is characterized by chronic clonal lymphoproliferation of cytotoxic T lymphocytes (CTLs).
249                      In another patient with lymphoproliferation of donor lymphocyte origin, blood EB
250 ated by EBV contribute to the characteristic lymphoproliferation of IM.
251  on 2 patients demonstrated that spontaneous lymphoproliferation of PBLs was present but decreased re
252                                              Lymphoproliferation of selected CD4+ T cells was shared
253 topic Epstein-Barr virus (EBV) infection and lymphoproliferation of T and/or NK cells.
254 erum antibodies to Chlamydia and significant lymphoproliferation of T-cells following stimulation wit
255 ion at 11 DPI but no detectable Env-specific lymphoproliferation or ex vivo gamma interferon (IFN-gam
256 ents the disease development without causing lymphoproliferation or immune suppression.
257 ctive immune disorders such as autoimmunity, lymphoproliferation, or atopy, but this coincidence is r
258 ey did not develop spontaneous autoimmunity, lymphoproliferation, or germinal center expansion althou
259  favorable impact on immune cell subsets and lymphoproliferation over placebo in patients with APDS o
260 ss-switched memory B cells and propensity to lymphoproliferation (P = .002) in patients with CVID.
261 esponses that trended higher than Dryvax for lymphoproliferation (P = .06), but lower for IFN-gamma E
262 m infants had diminished poliovirus-specific lymphoproliferation (P<.001).
263 ls (P=.02) and higher rubella virus-specific lymphoproliferation (P=.002).
264  that, at least in NZB, the autoimmunity and lymphoproliferation phenotypes are not linked geneticall
265 ts also emphasize the importance of IL-6 for lymphoproliferation, possibly through induction of IL-2R
266                      However, HIV-1-specific lymphoproliferation remained largely undetectable throug
267 ctivation was analyzed by flow cytometry and lymphoproliferation, respectively.
268 essing gp160/LAMP had greater gp160-specific lymphoproliferation responses and higher titers of anti-
269                                              Lymphoproliferation responses in vaccinia-nonnaive indiv
270  entity in which a bone marrow clonal B-cell lymphoproliferation results in autoimmune hemolytic anem
271                             This spontaneous lymphoproliferation (SP) is one of the immunologic hallm
272 L13, SPP1), activated B-cell subtype (MUM1), lymphoproliferation (SPP1, TCL1A, CHI3L1), aggressive cl
273 d individuals can result in malignant B cell lymphoproliferations, such as PTLD.
274 liferation and, in older mice, clonal B cell lymphoproliferation, suggesting that the DZ inertial cel
275 matologic illness involving cytokine-induced lymphoproliferation, systemic inflammation, cytopenias,
276 that the increase in cell numbers was due to lymphoproliferation that occurred in situ.
277 expressing T and B cell lymphomas, including lymphoproliferations that emerged spontaneously after EB
278                                     In these lymphoproliferations, the KSHV-infected cells carry the
279    Unexpectedly, there was no progression of lymphoproliferation through 24 weeks, even though immune
280                                              Lymphoproliferation to HHV-7 lysate was demonstrated in
281                          Marked increases in lymphoproliferation to HPV--11 L1 antigens were noted af
282                                  Significant lymphoproliferation to these peptides was observed in 12
283 autoimmune disease manifestations, including lymphoproliferation, vasculitis, glomerulonephritis, and
284 velop an autoimmune disease characterized by lymphoproliferation, vasculitis, glomerulonephritis, aut
285                              In one patient, lymphoproliferation was associated with high titres whic
286                                              Lymphoproliferation was completely suppressed in B6CD4KO
287 d monitoring strategy detecting peripheral B lymphoproliferation was effective in the early diagnosis
288 ibodies, and their effect on mitogen-induced lymphoproliferation was examined.
289 utations in 8 families, up to 48 years after lymphoproliferation was first documented.
290                                 In addition, lymphoproliferation was induced after vaccination in per
291  (purified protein derivative [PPD])-induced lymphoproliferation was markedly impaired in vaccinated
292 treat ALPS, and found rapamycin's control of lymphoproliferation was superior.
293 atory features were present in all patients: lymphoproliferation was the most common manifestation (7
294                       Virus antigen-specific lymphoproliferation was vigorous in some LTNPs.
295  mice in that the number of CLL among B-cell lymphoproliferations was significantly elevated in the f
296 nd NF-kappaB activation, IL-2 secretion, and lymphoproliferation were inhibited by fish oil feeding.
297 ells and peripheral tissues played a role in lymphoproliferation, whereas the skin disease phenotype
298                A hallmark of this disease is lymphoproliferation, which may even be life threatening
299 early onset and aggressive polyclonal T cell lymphoproliferation with concomitant B cell expansion an
300 eatment, all patients showed amelioration of lymphoproliferation with lymph node sizes and spleen vol

 
Page Top